Chad Wilkey currently serves as a Business Development Manager with bioMérieux Inc. focusing on their ENDONEXT™ platform utilizing recombinant Factor C for bacterial endotoxin testing. In this role he supports customers with innovative endotoxin detection technologies and quality assurance solutions. Chad has been with bioMérieux, Inc. for 27 years in various commercial operations roles in the pharmaceutical microbiology space. With his experience working alongside pharmaceutical manufacturers, contract laboratories and quality control teams, Chad combines technical knowledge with a practical, customer-focused approach helping organizations improve compliance, efficiency, and product quality